tradingkey.logo

Haleon PLC

HLN
查看詳細走勢圖
9.520USD
-0.070-0.73%
收盤 12/12, 16:00美東報價延遲15分鐘
85.53B總市值
38.90本益比TTM

Haleon PLC

9.520
-0.070-0.73%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.73%

5天

0.00%

1月

-0.73%

6月

-12.42%

今年開始到現在

-0.21%

1年

-2.46%

查看詳細走勢圖

TradingKey Haleon PLC股票評分

單位: USD 更新時間: 2025-12-12

操作建議

Haleon PLC當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在藥品行業排名72/159位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價10.58。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Haleon PLC評分

相關信息

行業排名
72 / 159
全市場排名
182 / 4592
所屬行業
藥品

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 4 分析師
買入
評級
10.579
目標均價
+12.54%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Haleon PLC亮點

亮點風險
Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
利潤高增長
公司淨利潤處於行業前列,最新年度總收入8.92B美元
高分紅
公司屬於高分紅公司,最新股息支付率41.40%
估值低估
公司最新PE估值38.90,處於3年歷史低位
機構減倉
最新機構持股570.14M股,環比減少2.78%
莫瑞·斯塔爾持倉
明星投資者莫瑞·斯塔爾持倉,最新持倉14.08K股
活躍度降低
近期活躍度降低,過去20天平均換手率0.10

Haleon PLC新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Haleon PLC簡介

Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
公司代碼HLN
公司Haleon PLC
CEOMcnamara (Brian)
網址https://www.haleon.com/

常見問題

Haleon PLC(HLN)的當前股價是多少?

Haleon PLC(HLN)的當前股價是 9.520。

Haleon PLC 的股票代碼是什麼?

Haleon PLC的股票代碼是HLN。

Haleon PLC股票的52週最高點是多少?

Haleon PLC股票的52週最高點是11.420。

Haleon PLC股票的52週最低點是多少?

Haleon PLC股票的52週最低點是8.710。

Haleon PLC的市值是多少?

Haleon PLC的市值是85.53B。

Haleon PLC的淨利潤是多少?

Haleon PLC的淨利潤為1.44B。

現在Haleon PLC(HLN)的股票是買入、持有還是賣出?

根據分析師評級,Haleon PLC(HLN)的總體評級為買入,目標價格為10.579。

Haleon PLC(HLN)股票的每股收益(EPS TTM)是多少

Haleon PLC(HLN)股票的每股收益(EPS TTM)是0.245。
KeyAI